+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Genetic changes including gene copy number alterations and their relation to prognosis in childhood acute myeloid leukemia



Genetic changes including gene copy number alterations and their relation to prognosis in childhood acute myeloid leukemia



Leukemia and Lymphoma 51(1): 114-124



We studied a series of 68 subjects diagnosed with childhood acute myeloid leukemia (AML) using conventional cytogenetics and fluorescence in situ hybridization (FISH), polymerase chain reaction (PCR) to analyze mutations in FLT3 and NPM1 genes, and/or array comparative genomic hybridization (CGH). Cytogenetic/FISH abnormalities were observed in 71% of subjects, FLT3-ITD mutations in 15%, and NPM1 mutations in 13%. The array CGH alterations (average 3.6 per case) were observed in 96% of the tested subjects. The most frequent alterations were gains of 8q24.3 and 11p15.5-p15.4 in 16% of the samples. Six genes (AKT1, RUNX1, LTB, SDC1, RUNX1T1, and JAK2) from the imbalanced regions have been reported to be involved in AML, whereas other 30 cancer genes, not previously reported in an AML context, were identified as imbalanced. They probably correspond to non passenger alterations that cooperate with the recurrent translocations. The clinical data and genetic changes were tested to find out the possible association with prognosis. Genomic instability (four or more genomic imbalances) was correlated with poor patient outcome (p = 0.029).

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053379887

Download citation: RISBibTeXText

PMID: 20001230

DOI: 10.3109/10428190903350397


Related references

Acquired copy number alterations in adult acute myeloid leukemia genomes. Proceedings of the National Academy of Sciences of the United States of America 106(31): 12950-5, 2009

Detection of copy number alterations in acute myeloid leukemia and myelodysplastic syndromes. Expert Review of Molecular Diagnostics 12(3): 253-264, 2012

IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication. Journal of Clinical Oncology 28(22): 3636-3643, 2010

Acquired copy number alterations of miRNA genes in acute myeloid leukemia are uncommon. Blood 122(15): E44-E51, 2013

TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome. Blood 119(9): 2114-2121, 2012

Copy number alterations in childhood acute lymphoblastic leukemia and their association with minimal residual disease. Genes Chromosomes and Cancer 47(6): 471-480, 2008

Significance of copy number alterations for molecular treatment response in childhood acute lymphoblastic leukemia. 2007

Copy Number Alterations Associated with Acute Lymphoblastic Leukemia in Mexican Children. A report from The Mexican Inter-Institutional Group for the identification of the causes of childhood leukemia. Archives of Medical Research 47(8): 706-711, 2017

Acute Myeloid Leukemia-Genetic Alterations and Their Clinical Prognosis. International Journal of Hematology-Oncology and Stem Cell Research 11(4): 328-339, 2017

Identification of RUNX1 gene breakage and copy number variation in acute myeloid leukemia. International Journal of Laboratory Hematology 38(2): E23-E26, 2016

Micro-RNAs and copy number changes: new levels of gene regulation in acute myeloid leukemia. Chemico-Biological Interactions 184(1-2): 21-25, 2010

Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1-positive acute lymphoblastic leukemia. Haematologica 99(4): 706-714, 2014

Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol. Haematologica 100(2): 214-222, 2015

Assessing copy number abnormalities and copy-neutral loss-of-heterozygosity across the genome as best practice in diagnostic evaluation of acute myeloid leukemia: An evidence-based review from the cancer genomics consortium (CGC) myeloid neoplasms working group. Cancer Genetics 228-229: 218-235, 2018

Correlation between myeloperoxidase expression and gene alterations and prognosis in acute myeloid leukemia. Zhonghua Xue Ye Xue Za Zhi 40(1): 40-45, 2019